32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care

Key Takeaways Explain This Topic AI

Palpitations represent the subjective perception of an abnormal heartbeat; characterization of the sensation ('flip-flopping/skipped beats' reflecting ectopy with post-extrasystolic pause, 'rapid regular fluttering' reflecting supraventricular tachycardia, or 'irregular chaotic pounding' reflecting atrial fibrillation) guides the initial diagnostic monitoring strategy.

A baseline 12-lead ECG is mandatory for every patient presenting with palpitations to evaluate for channelopathies, pre-excitation, and conduction abnormalities: Wolff-Parkinson-White (short PR <120 ms, delta wave), prolonged QTc (>450 ms in men, >460 ms in women, >500 ms conferring high risk of Torsades de Pointes), Brugada pattern (coved ST elevation ≥2 mm in V1-V2), ARVC (epsilon wave in V1-V3), and LVH with strain.

Ambulatory electrocardiographic monitoring selection is dictated by symptom frequency: a 24- to 48-hour Holter monitor is indicated for daily symptoms; a 14- to 30-day continuous patch or symptom-triggered event monitor is indicated for weekly to monthly intermittent episodes; and an implantable loop recorder (ILR) is reserved for infrequent (<monthly) or high-risk syncope/palpitations after negative non-invasive testing.

High-risk red flag features—including exertional presyncope or syncope, associated angina, acute dyspnea, personal history of structural heart disease, or a family history of unexplained sudden cardiac death under age 40 or inherited channelopathies—require urgent cardiology referral or emergency department transfer.

Initial primary care laboratory evaluation includes serum TSH and free T4 (hyperthyroidism), basic metabolic panel (hypokalemia, hypomagnesemia), complete blood count (anemia), and urine toxicology screening (sympathomimetic stimulants such as cocaine, amphetamines, and OTC decongestants); transthoracic echocardiography is indicated for any abnormal ECG, cardiac murmur, syncope, or suspected structural heart disease.

Last updated: September 2026

Clinical Overview & Pathophysiologic Mechanisms

Palpitations are defined as a conscious, unpleasant awareness of the heartbeat, described variously by patients as pounding, racing, fluttering, skipping, or jumping in the chest or neck. Palpitations account for approximately 16% of all outpatient cardiology referrals and represent the second most common cardiac complaint encountered in primary care following chest pain.

Pathophysiologic Etiologies

Extensive prospective ambulatory cohorts demonstrate that the etiologies of palpitations fall into five primary categories:

Cardiac Arrhythmias and Structural Cardiac Disease (~40% to 45%) : Premature ventricular contractions (PVCs), premature atrial contractions (PACs), paroxysmal supraventricular tachycardia (PSVT, including atrioventricular nodal reentrant tachycardia [AVNRT] and atrioventricular reentrant tachycardia [AVRT]), atrial fibrillation (AFib), atrial flutter, ventricular tachycardia (VT), sick sinus syndrome, mitral valve prolapse (MVP), and aortic stenosis.

Psychiatric and Psychosomatic Conditions (~30% to 35%) : Panic disorder, generalized anxiety disorder, major depressive disorder, and somatic symptom disorder. Catecholamine surges amplify physiologic cardiac awareness.

Exogenous Substances, Toxins, and Medications (~10% to 15%) : Caffeine, alcohol binge consumption ("Holiday Heart Syndrome"), nicotine, prescription or illicit sympathomimetics (pseudoephedrine, phenylephrine, albuterol, amphetamines, cocaine, 3,4-methylenedioxymethamphetamine [MDMA]), theophylline, thyroid hormone overreplacement, and abrupt withdrawal of chronic beta-blockers or clonidine.

Non-Cardiac Medical and Endocrine Disorders (~5% to 10%) : Hyperthyroidism / thyrotoxicosis, severe anemia (hyperdynamic circulation), fever and systemic sepsis, pregnancy, hypoglycemia, hypoxemia, pheochromocytoma, and severe electrolyte disturbances (hypokalemia, hypomagnesemia, hypocalcemia).

Idiopathic / Unexplained (~5% to 10%) : No structural, electrical, metabolic, or psychological etiology identified despite exhaustive monitoring. ETIOLOGIC SPECTRUM OF PALPITATIONS

• ┌─────────────────────────────────────────────────────────────┐
• │ Cardiac Arrhythmias & Structural (~43%) │
• │ • PVCs / PACs (Ectopy) • Atrial Fibrillation / Flutter│
• │ • AVNRT / AVRT (PSVT) • Ventricular Tachycardia (VT)│
• ├─────────────────────────────────────────────────────────────┤
• │ Psychiatric Disorders (~31%) │
• │ • Panic Disorder • Generalized Anxiety Disorder│
• ├─────────────────────────────────────────────────────────────┤
• │ Exogenous & Toxic (~10%) │
• │ • Caffeine / Stimulants • Alcohol ("Holiday Heart") │
• │ • Decongestants / Cocaine • Beta-blocker withdrawal │
• ├─────────────────────────────────────────────────────────────┤
• │ Systemic Medical (~10%) │ Idiopathic (~6%) │
• │ • Hyperthyroidism / Anemia │ • Benign awareness │
• │ • Pheochromocytoma / Hypo-K+ │ │
• └─────────────────────────────────────────────────────────────┘
• Comprehensive History & Diagnostic Symptom Classification

A meticulous history is the single most powerful diagnostic tool in primary care. Having the patient tap out the rhythm with their fingers on the examination table frequently clarifies the underlying electrophysiologic mechanism faster than verbal descriptions.

Clinical Rhythm Characterization

"Flip-Flopping", "Thumping", or "Skipped Beats" : Typically describes isolated premature atrial contractions (PACs) or premature ventricular contractions (PVCs) . The subjective sensation is rarely the ectopic beat itself; rather, it represents the post-extrasystolic compensatory pause followed by augmented ventricular filling, resulting in a hyperdynamic stroke volume on the subsequent normal sinus beat that forcefully impacts the anterior chest wall.

Rapid, Perfectly Regular Fluttering with Sudden "On/Off" Switching : Strongly indicates paroxysmal supraventricular tachycardia (PSVT) , most commonly AVNRT or AVRT. The arrhythmia begins abruptly without a warm-up phase and terminates abruptly (paroxysmal), often spontaneously or following vagal maneuvers (e.g., Valsalva, coughing, splashing cold water on the face).

Rapid, Irregularly Irregular, Chaotic Racing : Characteristic of atrial fibrillation or, less commonly, atrial flutter with variable atrioventricular conduction or multifocal atrial tachycardia (MAT).

Pounding Sensation in the Neck ("Frog Sign") : Hallmark of AVNRT . Simultaneous contraction of the atria and ventricles against closed atrioventricular (tricuspid and mitral) valves produces retrograde pressure waves through the superior vena cava, visible and felt as prominent jugular venous cannon a waves in the neck.

Precipitating Triggers and Modulating Factors

Substances : High caffeine intake (energy drinks), heavy binge alcohol intake ("Holiday Heart Syndrome" precipitating new-onset atrial fibrillation in otherwise healthy young individuals), over-the-counter nasal decongestants containing pseudoephedrine or phenylephrine, dietary weight-loss supplements containing ephedra or bitter orange (synephrine), and herbal stimulants.

Exertion vs. Rest : Palpitations occurring solely during peak physical exertion suggest exercise-induced ventricular arrhythmias, catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic cardiomyopathy, or ischemia-driven arrhythmias. In contrast, palpitations occurring when lying quietly in bed at night typically represent benign PACs/PVCs or heightened somatic awareness.

Positional Triggers : Palpitations provoked immediately by bending forward or stooping often indicate AVNRT triggered by transient shifts in intrathoracic pressure and autonomic tone.

High-Risk Red Flags Mandating Immediate Triage

Primary care clinicians must rapidly identify red flag symptoms and historical features that signify life-threatening arrhythmogenic risk, warranting direct emergency department transfer or urgent inpatient cardiology admission:

High-Risk Feature Clinical Significance & Underlying Pathophysiology

Exertional Presyncope or Syncope Critical red flag. Strongly suggests hemodynamically unstable ventricular tachycardia, severe left ventricular outflow tract obstruction (HOCM, severe aortic stenosis), or high-grade AV block.

Associated Anginal Chest Discomfort Indicates myocardial ischemia triggering secondary ventricular ectopy/VT, or severe tachyarrhythmia inducing coronary supply-demand mismatch in significant coronary artery disease.

Acute Dyspnea or Heart Failure Symptoms Orthopnea, paroxysmal nocturnal dyspnea, or crackles suggest tachycardiomyopathy, acute decompensated heart failure, or severe valvular regurgitation.

Known Structural Heart Disease Prior myocardial infarction, left ventricular systolic dysfunction (LVEF <40%), ischemic or dilated cardiomyopathy, or congenital heart repairs markedly increase the risk of sustained monomorphic VT and sudden cardiac death.

Family History of Premature Sudden Death Unexplained sudden death, drowning, or single-vehicle motor accidents in first-degree relatives <40 years of age strongly points to inherited arrhythmogenic conditions: Long QT syndrome, Brugada syndrome, Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), or Hypertrophic Cardiomyopathy (HCM).

Sustained Heart Rate >150 bpm with Hemodynamic Instability SBP <90 mmHg, altered mental status, or diaphoresis requires immediate synchronized cardioversion.

Resting 12-Lead Electrocardiogram (ECG) Checklist

A 12-lead resting ECG must be obtained in every patient presenting with palpitations, even if the patient is currently asymptomatic. While the rhythm is usually normal sinus during the clinic visit, the baseline ECG provides essential clues regarding underlying structural heart disease, conduction abnormalities, and inherited channelopathies. 12-LEAD ECG EVALUATION CHECKLIST IN PALPITATIONS

• 1. RATE & RHYTHM ──> Sinus brady/tachycardia, PACs, PVCs, AFib/Flutter
• 2. PR INTERVAL ──> Short (<120 ms) with Delta Wave = WPW Syndrome
• Prolonged (>200 ms) = First-degree AV Block
• 3. QRS DURATION/SHAPE ──> Wide (>120 ms) = BBB, Ventricular pacing
• Epsilon Wave in V1-V3 = ARVC/ARVD
• 4. ST-T WAVE MORPHOLOGY──> Coved ST-elevation V1-V2 (≥2 mm) = Brugada Type 1
• Asymmetric lateral T-inversions = LVH with Strain
• 5. QTc INTERVAL ──> Prolonged (>450 ms men, >460 ms women, >500 ms critical)
• Detailed Electrocardiographic Targets

Wolff-Parkinson-White (WPW) Pattern & Pre-Excitation :

Criteria : Short PR interval (<120 ms), slurred initial upstroke of the QRS complex ( delta wave ), widened QRS duration (>120 ms), and secondary ST-T wave discordance.

Clinical Significance : Represents an accessory atrioventricular pathway (Bundle of Kent). In the setting of atrial fibrillation, rapid conduction down the accessory pathway bypasses the rate-limiting AV node, allowing ventricular rates to exceed 250-300 bpm, potentially degenerating into ventricular fibrillation and sudden death.

Exam Pearl : AV nodal blocking drugs ( adenosine, beta-blockers, non-dihydropyridine calcium channel blockers, digoxin ) are strictly contraindicated in pre-excited AFib because blocking the AV node shunts 100% of impulses down the accessory pathway, precipitating ventricular fibrillation.

Long QT Syndrome (LQTS) :

Measurement : Bazett-corrected QT interval: QTc = QT / √(RR).

Thresholds :

Normal: <450 ms in men; <460 ms in women.

Borderline: 450 to 470 ms in men; 460 to 480 ms in women.

Prolonged: >470 ms in men; >480 ms in women.

Severely Prolonged / High Arrhythmic Risk : >500 ms .

Pathology : Predisposes to pause-dependent polymorphic ventricular tachycardia ( Torsades de Pointes ). Can be congenital (KCNQ1, KCNH2, SCN5A mutations) or acquired (hypokalemia, hypomagnesemia, and culprit medications such as macrolides, fluoroquinolones, citalopram, haloperidol, ondansetron, methadone, amiodarone, and sotalol).

Brugada Syndrome :

Type 1 Morphology : Coved ST-segment elevation ≥2 mm (0.2 mV) in ≥1 right precordial lead (V1, V2), followed by a negative, symmetric T wave.

Genetics & Risk : Autosomal dominant loss-of-function mutation in the cardiac sodium channel gene SCN5A . Markedly elevates risk of polymorphic VT and ventricular fibrillation, predominantly during sleep or febrile illness. Unmasked by fever, sodium channel blockers (flecainide, procainamide), and tricyclic antidepressants.

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC / ARVD) :

Findings : Epsilon wave (a distinct low-amplitude terminal notch or deflection at the end of the QRS complex before the ST segment in leads V1 to V3), localized QRS prolongation (>110 ms) in V1-V3, and inverted T waves in V1-V3 in individuals >14 years of age.

Pathology : Fibrofatty replacement of the right ventricular myocardium leading to reentrant ventricular arrhythmias and sudden cardiac death in young athletes.

Left Ventricular Hypertrophy (LVH) with Repolarization Abnormality (Strain) :

Sokolow-Lyon Criteria : S in V1 + R in V5 or V6 ≥ 35 mm.

Cornell Voltage Criteria : R in aVL + S in V3 > 28 mm (men) or > 20 mm (women).

Significance : Asymmetric ST-segment depression and T-wave inversion in lateral leads (I, aVL, V5, V6) reflects subendocardial ischemia from chronic hypertensive remodeling or hypertrophic cardiomyopathy.

Ambulatory Electrocardiographic Monitoring Modality Selection

Because palpitations are episodic, the resting 12-lead ECG is frequently normal. The diagnostic yield of ambulatory electrocardiographic monitoring depends entirely on matching the device's recording window to the patient's reported symptom frequency:

Monitoring Device Duration of Wear Recording Mechanism Primary Indications Key Advantages & Practical Limitations

Holter Monitor 24 to 48 hours Continuous recording of all beats across 2 to 7 leads Daily or near-daily symptoms (multiple episodes per 24 hours); assessing 24-hour total PVC burden or baseline rate control Advantage : Full beat-by-beat quantification of ectopy burden.; Limitation : Very low diagnostic yield (<10-15%) if symptoms occur less frequently than daily.

Continuous Adhesive Patch Monitor (e.g., Zio XT, BioTel) 7 to 14 days Continuous single-lead recording stored on internal memory Symptoms occurring several times per week (weekly episodes); subclinical atrial fibrillation screening Advantage : High patient compliance, leadless, water-resistant for showering.; Limitation : Single lead limits detailed bundle branch block analysis; delayed turnaround (mailed for analysis).

External Loop / Event Recorder 14 to 30 days Symptom-activated or auto-triggered continuous looping memory Intermittent symptoms occurring weekly to monthly (every 1 to 4 weeks) Advantage : Looping memory saves 30-60 seconds prior to button activation (captures rhythm leading up to presyncope).; Limitation : Requires manual activation for symptoms; bulky electrodes can cause skin irritation.

Implantable Loop Recorder (ILR) 3 to 5 years Subcutaneously implanted auto-sensing and patient-activated monitor Infrequent symptoms (<once monthly) ; recurrent unexplained syncope with high suspicion of arrhythmia; cryptogenic stroke workup Advantage : Gold standard for rare, high-stakes events; continuous remote wireless transmission.; Limitation : Minor surgical minor procedure required; costly. AMBULATORY MONITOR SELECTION BASED ON SYMPTOM FREQUENCY

• Frequency: DAILY ──────────> WEEKLY ──────────> MONTHLY / RARE
• │ │ │
• Modality: 24-48h Holter 7-14d Patch / 14-30d Event Recorder
• Monitor Continuous Loop or ILR (if syncope)
• Targeted Laboratory Evaluation & Transthoracic Echocardiogram
• Primary Care Laboratory Workup

Routine laboratory testing is indicated in newly presenting palpitations to identify correctable systemic and metabolic drivers:

Serum Thyroid-Stimulating Hormone (TSH) and Free T4 : Unmasks overt or subclinical hyperthyroidism and toxic multinodular goiter.

Basic Metabolic Panel (BMP) with Serum Magnesium : Detects hypokalemia (<3.5 mEq/L), hypomagnesemia (<1.8 mg/dL), and renal dysfunction that alters drug clearance. Hypokalemia and hypomagnesemia lower the myocardial resting membrane potential, triggering triggered activity and early afterdepolarizations.

Complete Blood Count (CBC) : Evaluates for severe anemia (hemoglobin <8 g/dL), which causes compensatory resting tachycardia and hyperdynamic flow murmurs.

Urine Toxicology Screen : Recommended when palpitations arise in young adults without prior history, or when clinical signs of sympathetic excess (diaphoresis, mydriasis, hypertension) are present, screening for cocaine, amphetamines, and cannabis.

Indications for Transthoracic Echocardiography (TTE)

Transthoracic echocardiography is not required for every patient with isolated, infrequent, benign ectopy. However, TTE is strongly indicated in the presence of:

Any abnormal finding on the 12-lead ECG (pathologic Q waves, bundle branch block, LVH, ischemic ST-T changes).

Any pathologic cardiac murmur on physical examination (e.g., systolic ejection murmur radiating to carotids, holosystolic apical murmur of mitral regurgitation, mid-systolic click of MVP).

Any episode of exertional presyncope or syncope.

Symptoms suggestive of congestive heart failure (peripheral edema, orthopnea, elevated jugular venous pressure).

Documented sustained arrhythmia or high ectopy burden (>5% to 10% PVC burden on Holter monitor) to rule out structural cardiomyopathy or tachycardiomyopathy.

• Outpatient Management, Risk Stratification & Referral Criteria
• Low-Risk Ambulatory Management (Benign Ectopy)

When the diagnostic workup (ECG, laboratories, and ambulatory monitoring) confirms benign PACs or isolated low-burden PVCs (<1% of total beats) in the absence of structural heart disease:

Patient Education and Reassurance : Explain the physiology of the compensatory pause; reassure the patient regarding the benign prognosis.

Trigger Elimination : Eliminate caffeine, energy drinks, alcohol, tobacco, and sympathomimetic nasal sprays.

Symptom-Targeted Pharmacotherapy : If palpitations cause disabling distress or functional impairment despite reassurance, initiate a low-dose cardioselective beta-blocker ( metoprolol succinate 25 to 50 mg PO daily or atenolol 25 mg PO daily ) or a non-dihydropyridine calcium channel blocker ( diltiazem extended-release 120 to 180 mg PO daily ), provided no conduction disease exists.

Criteria for Emergent Transfer vs. Urgent Cardiology Referral

Emergency Department Transfer (EMS / 911) : Palpitations accompanied by hemodynamic instability (systolic BP <90 mmHg), sustained wide-complex tachycardia on ECG, acute anginal chest pressure, syncope with injury, or acute pulmonary edema.

Urgent Cardiology / Electrophysiology Referral : Documented WPW pattern on ECG; prolonged QTc (>500 ms); Brugada pattern; ARVC criteria; high PVC burden (>10% to 15% on Holter, which carries long-term risk of PVC-induced dilated cardiomyopathy); paroxysmal atrial fibrillation; or recurrent paroxysmal SVT requiring catheter ablation.

Loading diagram... Ambulatory Triage and Diagnostic Pathway for Palpitations